# Imipenem and Cilastatin

NDC: 63323-322
Generic name: Imipenem and Cilastatin Sodium
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20120103

FDA application: ANDA090577

## Active ingredients

- CILASTATIN SODIUM: 500 mg/20mL
- IMIPENEM: 500 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-322"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-322
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ab0ca9e-9a79-4cab-9f09-470eda06952e